• Home
  • News
    • Editorial
    • MD(e)B(unker)
    • Related Researches
      • Di Bella's Foundation
      • 1960-1969
      • 1970-1979
      • 1980-1989
      • 1990-1999
      • 2000-2009
      • 2010-2019
      • 2020-2029
    • Science news
    • Scientific Documentation
  • About us...
    • Biography
    • Bibliography
  • The Method
    • Di Bella's Method!
    • 1998 Trial!
  • Media
    • Video Publications
    • News-PapersNews-Papers
      • Press
    • TestimonialTestimonial
      • Testimonies
    • Video GalleryVideo Gallery
      • Congresses
      • Video Testimonies
      • TV & C.
  • Case History
    • Medical reports
      • Lung
      • Lymphomas
        • Non-Hodgkin Lymphomas
        • Hodgkin Lymphomas
      • Mediastinum
      • Mesothelioma
      • Myeloma
      • Pancreas
      • Scientific Publications
  • F.A.Q.
  • Useful Links
    • User Side
      • Vademecum
    • CouponChief - Resources for Cancer Patients
  • Contact Us
Home page   News   Related Researches  
Title Created Date
Octreotide in Palliative Treatment of Hepatic Metastases: Is it Effective for Clinical Stabilization? 16 January 2014
Treatment of hepatocellular cancer with the long acting somatostatin analog lanreotide in vitro and in vivo 16 January 2014
Growth-inhibitory activity of melatonin on human androgen-independent DU 145 prostate cancer cells 08 January 2014
The expression of MT1 melatonin receptor and Ki-67 antigen in melanoma malignum 03 January 2014
Immunohistochemical determination of the growth hormone receptor in squamous cell carcinoma of the skin 03 January 2014
Novel modalities of somatostatin actions 01 January 2014
Melatonin-estrogen interactions in breast cancer 01 January 2014
Rationale for the use of somatostatin analogs as antitumor agents 30 December 2013
Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells 29 December 2013
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition 28 December 2013
Display # 

Page 94 of 111

  • Start
  • Prev
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • Next
  • End

Search

Follow us...

Latest

  • The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells
  • Somatostatin and the treatment of cancer
  • Somatostatin and analogues in the treatment of cancer. A review
  • A retrospective observational study on cases of osteosarcomas treated with a multitherapy: The rationale and effectiveness
  • Somatostatin in oncology, the overlooked evidences
  • The Di Bella Method (DBM) in the treatment of prostate cancer: a preliminary retrospective study of 16 patients and a review of the literature
  • Melatonin induces apoptosis in human neuroblastoma cancer cells
  • Evidence for a biphasic apoptotic pathway induced by melatonin in MCF-7 breast cancer cells
  • Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions
  • Consequences of lethal-whole-body gamma radiation and possible ameliorative role of melatonin
  • Antiproliferative activity of melatonin by transcriptional inhibition of cyclin D1 expression: a molecular basis for melatonin-induced oncostatic effects
  • Complete objective response of oesophageal squamocellular carcinoma to biological treatment
  • The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 55 cases of lymphomas
  • Can Melatonin Help Us in Radiation Oncology Treatments?
  • A radiobiological review on melatonin: a novel radioprotector
  • Immunomodulatory effect of melatonin in SK-LU-1 human lung adenocarcinoma cells co-cultured with peripheral blood mononuclear cells
  • Mechanisms Underlying Tumor Suppressive Properties of Melatonin
  • Melatonin induces apoptosis through a caspase-dependent but reactive oxygen species-independent mechanism in human leukemia Molt-3 cells

Most Read

  • The Di Bella Method (DBM)
  • About melatonin - 1996
  • All-trans-retinoic acid and cancer
  • Biography
  • The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
  • Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
  • Somatostatin in oncology, the overlooked evidences
  • Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
  • How effective is chemo therapy?
  • Complete objective response to biological therapy of plurifocal breast carcinoma
  • Bibliography
  • Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
  • Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
  • Vademecum
  • Frequently Asked Questions
  • Declaration recommends eliminate the use of Impact factor for research evaluation
  • Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
  • Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer